Piscataway, N.J. – September 28, 2026 -- Sampled has secured a five-year contract worth up to $27.1 million from the Department of Veterans Affairs to provide genomics analyses for the Million Veteran Program (MVP), one of the world's largest research initiatives of its kind.
MVP has enrolled more than one million veterans since its 2011 launch
The program studies how molecular factors, lifestyle, and service-related experiences drive elevated veteran health risks, including PTSD, cardiovascular disease, and cancer. Published MVP findings have already advanced understanding of PTSD, artery disease, suicide risk, stroke, and substance use.
Sampled operates among the largest US fleets of PacBio Revio sequencers
The company will continue providing array genotyping, long-read whole genome sequencing, DNA methylation analysis, and proteomics assays under the renewed contract. Sampled's CAP-accredited biobanking and CLIA-licensed lab operations support scalable, automated processing across diverse biospecimen types donated by MVP participants.
CEO John DelliSanti frames the award as validation of longitudinal research capacity
"The renewed trust placed in Sampled by the Department of Veterans Affairs reflects the quality, reliability, and scale of our genomics capabilities," said DelliSanti, Chief Executive Officer at Sampled.